Ed Venkat
Geen lopende functies
Profiel
Ed Venkat worked as a Director of Process Development at GlobeImmune, Inc. and as a Director of Pharmaceutical Development at Cleveland BioLabs, Inc. from 2010 to 2011.
He holds a doctorate degree from Rutgers State University of New Jersey, a graduate degree from Stevens Institute of Technology, and a graduate degree from Indian Institute of Technology New Delhi.
Eerdere bekende functies van Ed Venkat
| Bedrijven | Functie | Einde |
|---|---|---|
| GLOBEIMMUNE, INC. | Corporate Officer/Principal | - |
| STATERA BIOPHARMA, INC. | Corporate Officer/Principal | - |
Opleiding van Ed Venkat
| Indian Institute of Technology New Delhi | Graduate Degree |
| Rutgers State University of New Jersey | Doctorate Degree |
| Stevens Institute of Technology | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| GLOBEIMMUNE, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Cleveland BioLabs, Inc.
 Cleveland BioLabs, Inc. Pharmaceuticals: MajorHealth Technology Cleveland BioLabs, Inc. operates as a biopharmaceutical company, which engages in the research and development of drugs. It focuses on oncology and acute radiation syndrome. It offers Entolimod, Mobilan, CBL0137, and SA-702. The company was founded by Andrei V. Gudkov and Yakov Kogan on June 5, 2003 and is headquartered in Buffalo, NY. | Health Technology |
